ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
66,388.65
-0.38%
S&P 500
5,473.23
0.77%
Dow Jones
38,778.10
0.49%
US Dollar vs Yen
157.717
0.20%
Brent Oil
83.875
2.13%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. USOTC
  6. Innate Pharma (PK) (IPHYF)

  7. Innate Pharma (PK) (IPHYF) ニュース

IPHYF

Innate Pharma (PK) (IPHYF)

Innate Pharma (PK)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:USOTC:IPHYF
日付受信時刻ニュースソース見出しコード企業名
2024/06/1719 : 02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPHYFInnate Pharma (PK)
2024/05/1419 : 07Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPHYFInnate Pharma (PK)
2024/05/0719 : 03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPHYFInnate Pharma (PK)
2024/03/0620 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPHYFInnate Pharma (PK)
2024/03/0620 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPHYFInnate Pharma (PK)
2024/02/2120 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPHYFInnate Pharma (PK)
2024/02/0707 : 05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPHYFInnate Pharma (PK)
2024/02/0707 : 00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]USOTC:IPHYFInnate Pharma (PK)
2023/12/1920 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPHYFInnate Pharma (PK)
2023/12/1901 : 40Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPHYFInnate Pharma (PK)
2023/12/1120 : 01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPHYFInnate Pharma (PK)
2023/12/1120 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPHYFInnate Pharma (PK)
2023/11/2720 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPHYFInnate Pharma (PK)
2023/11/0720 : 01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPHYFInnate Pharma (PK)
2023/10/1619 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPHYFInnate Pharma (PK)
2023/10/0519 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPHYFInnate Pharma (PK)
2023/09/2219 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPHYFInnate Pharma (PK)
2023/08/1019 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPHYFInnate Pharma (PK)
2023/06/2619 : 03Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:IPHYFInnate Pharma (PK)
2023/06/1219 : 45Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:IPHYFInnate Pharma (PK)
2023/06/1219 : 44Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:IPHYFInnate Pharma (PK)
2023/06/0819 : 02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:IPHYFInnate Pharma (PK)
2023/06/0719 : 03Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:IPHYFInnate Pharma (PK)
2023/05/2619 : 05Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:IPHYFInnate Pharma (PK)
2023/05/1519 : 28Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:IPHYFInnate Pharma (PK)
2023/05/1305 : 01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:IPHYFInnate Pharma (PK)
2023/05/1019 : 05Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:IPHYFInnate Pharma (PK)
2023/05/0919 : 05Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:IPHYFInnate Pharma (PK)
2023/04/2705 : 04Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:IPHYFInnate Pharma (PK)
2023/04/2705 : 03Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:IPHYFInnate Pharma (PK)
 Showing the most relevant articles for your search:USOTC:IPHYF

最近閲覧した銘柄

NASDAQ
MSFT
Microsoft
COIN
ETHUSD
Ethereum
NYSE
VZ
Verizon Communications
AMEX
XLF
Financial Select Sector
USOTC
BNPQY
BNP Paribas (QX)
USOTC
DTEGY
Deutsche Telekom (QX)
CCOM
US500
US 500
CCOM
US30
US 30
NYSE
XOM
Exxon Mobil
COIN
BTCUSD
Bitcoin
NASDAQ
GOOGL
Alphabet
NYSE
DIS
Walt Disney
PM
XAUUSD
Gold vs US Dollar
FX
USDJPY
US Dollar vs Yen
USOTC
ADDYY
Adidas (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有